FdaApplication
ANDA 207717
Identifiers
- fda_app_no: ANDA207717
Properties
| Property | Value |
|---|---|
| applicant_name | RUBICON RESEARCH LTD |
| application_type | ANDA |
| approval_date | 2024-03-05 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OXCARBAZEPINE | OXCARBAZEPINE | 300MG | TABLET;ORAL |
| OXCARBAZEPINE | OXCARBAZEPINE | 150MG | TABLET;ORAL |
| OXCARBAZEPINE | OXCARBAZEPINE | 600MG | TABLET;ORAL |
3 products